Device
CES
CES is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Recruiting1
Terminated1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
terminated133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
The Effect of Cranial Electrotherapy Stimulation on the Cognition, Anxiety, Depression and Sleep Quality of Chronic Psychiatric Patients
NCT06966921
terminatednot_applicable
Cranial Electrical Stimulation (CES) as Treatment for Insomnia in Patients With Subacute Stroke
NCT03344562
completednot_applicable
Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization
NCT03060122
Clinical Trials (3)
Showing 3 of 3 trials
NCT06966921Not Applicable
The Effect of Cranial Electrotherapy Stimulation on the Cognition, Anxiety, Depression and Sleep Quality of Chronic Psychiatric Patients
NCT03344562Not Applicable
Cranial Electrical Stimulation (CES) as Treatment for Insomnia in Patients With Subacute Stroke
NCT03060122Not Applicable
Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3